RIGVIR溶瘤病毒疗法病毒及其他5种艾柯病毒7分离株的基因组序列
Genome Sequences of RIGVIR Oncolytic Virotherapy Virus and Five Other Echovirus 7 Isolates.
作者信息
Hietanen Eero, Smura Teemu, Hakanen Marika, Chansaenroj Jira, Merilahti Pirjo, Nevalainen Janne, Pandey Sunita, Koskinen Satu, Tripathi Lav, Poovorawan Yong, Pursiheimo Juha, Susi Petri
机构信息
Institute of Biomedicine, University of Turku, Turku, Finland.
Medicum, University of Helsinki, Helsinki, Finland.
出版信息
Genome Announc. 2018 Apr 26;6(17):e00317-18. doi: 10.1128/genomeA.00317-18.
Abstract
We report here the nearly complete Illumina-sequenced consensus genome sequences of six isolates of echovirus 7 (E7), including oncolytic virotherapy virus RIGVIR and the Wallace prototype. Amino acid identities within the coding region were highly conserved across all isolates, ranging from 95.31% to 99.73%.
摘要
我们在此报告了6株埃可病毒7型（E7）分离株的近乎完整的Illumina测序一致性基因组序列，包括溶瘤病毒疗法病毒RIGVIR和华莱士原型株。所有分离株编码区内的氨基酸同一性高度保守，范围在95.31%至99.73%之间。
相似文献
1
Genome Sequences of RIGVIR Oncolytic Virotherapy Virus and Five Other Echovirus 7 Isolates.RIGVIR溶瘤病毒疗法病毒及其他5种艾柯病毒7分离株的基因组序列
Genome Announc. 2018 Apr 26;6(17):e00317-18. doi: 10.1128/genomeA.00317-18.
2
Cytolytic Properties and Genome Analysis of Rigvir Oncolytic Virotherapy Virus and Other Echovirus 7 Isolates.溶细胞特性和基因组分析 Rigvir 溶瘤病毒治疗病毒和其他肠道病毒 7 分离株。
Viruses. 2022 Mar 4;14(3):525. doi: 10.3390/v14030525.
3
Reply to Alberts, P. Comment on "Hietanen et al. Cytolytic Properties and Genome Analysis of Rigvir Oncolytic Virotherapy Virus and Other Echovirus 7 Isolates. 2022, , 525".回复 Alberts，P. 对“Hietanen 等人的溶细胞特性和基因组分析 Rigvir 溶瘤病毒治疗病毒和其他肠道病毒 7 分离株。2022 年，，525”的评论。
Viruses. 2022 Sep 19;14(9):2078. doi: 10.3390/v14092078.
4
Comment on Hietanen et al. Cytolytic Properties and Genome Analysis of Rigvir Oncolytic Virotherapy Virus and Other Echovirus 7 Isolates. 2022, , 525.评 Hietanen 等人的《Rigvir 溶瘤病毒治疗的细胞溶解特性和基因组分析及其他肠道病毒 7 分离株》。2022 年， ，525 页。
Viruses. 2022 Sep 19;14(9):2076. doi: 10.3390/v14092076.
5
The advent of oncolytic virotherapy in oncology: The Rigvir® story.肿瘤溶瘤病毒治疗在肿瘤学中的应用：Rigvir®的故事。
Eur J Pharmacol. 2018 Oct 15;837:117-126. doi: 10.1016/j.ejphar.2018.08.042. Epub 2018 Sep 1.
6
Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient-three case reports.一名IV期M1c黑色素瘤患者、一名IIIA期小细胞肺癌患者和一名IV期组织细胞肉瘤患者接受溶瘤ECHO-7病毒Rigvir的长期治疗——三例病例报告
APMIS. 2016 Oct;124(10):896-904. doi: 10.1111/apm.12576. Epub 2016 Jul 26.
7
Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma.溶瘤病毒疗法，包括 Rigvir 和恶性黑色素瘤的标准疗法。
Oncolytic Virother. 2017 Feb 9;6:11-18. doi: 10.2147/OV.S100072. eCollection 2017.
8
Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery.一名IV期结直肠癌患者采用FOLFOX-4、贝伐单抗、Rigvir溶瘤病毒及手术的多模式治疗
Case Rep Gastroenterol. 2018 Aug 23;12(2):457-465. doi: 10.1159/000492210. eCollection 2018 May-Aug.
9
A progressive stage IIIB melanoma treated with oncolytic ECHO-7 virus: A case report.1例采用溶瘤性ECHO-7病毒治疗的进展期IIIB期黑色素瘤：病例报告
SAGE Open Med Case Rep. 2020 Jun 23;8:2050313X20934978. doi: 10.1177/2050313X20934978. eCollection 2020.
10
Stage IIA Skin Melanoma Treatment With ECHO-7 Oncolytic Virus Rigvir.ECHO-7 溶瘤病毒 Rigvir 治疗 IIA 期皮肤黑色素瘤。
Perm J. 2022 Sep 14;26(3):139-144. doi: 10.7812/TPP/21.232. Epub 2022 Aug 11.
引用本文的文献
1
Comment on Hietanen et al. Cytolytic Properties and Genome Analysis of Rigvir Oncolytic Virotherapy Virus and Other Echovirus 7 Isolates. 2022, , 525.评 Hietanen 等人的《Rigvir 溶瘤病毒治疗的细胞溶解特性和基因组分析及其他肠道病毒 7 分离株》。2022 年， ，525 页。
Viruses. 2022 Sep 19;14(9):2076. doi: 10.3390/v14092076.
2
Cytolytic Properties and Genome Analysis of Rigvir Oncolytic Virotherapy Virus and Other Echovirus 7 Isolates.溶细胞特性和基因组分析 Rigvir 溶瘤病毒治疗病毒和其他肠道病毒 7 分离株。
Viruses. 2022 Mar 4;14(3):525. doi: 10.3390/v14030525.
本文引用的文献
1
Polio and Measles Down the Drain: Environmental Enterovirus Surveillance in the Netherlands, 2005 to 2015.脊髓灰质炎和麻疹成为历史：2005年至2015年荷兰肠道病毒环境监测
Appl Environ Microbiol. 2017 Jun 16;83(13). doi: 10.1128/AEM.00558-17. Print 2017 Jul 1.
2
Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient-three case reports.一名IV期M1c黑色素瘤患者、一名IIIA期小细胞肺癌患者和一名IV期组织细胞肉瘤患者接受溶瘤ECHO-7病毒Rigvir的长期治疗——三例病例报告
APMIS. 2016 Oct;124(10):896-904. doi: 10.1111/apm.12576. Epub 2016 Jul 26.
3
MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets.MEGA7：适用于更大数据集的分子进化遗传学分析版本7.0
Mol Biol Evol. 2016 Jul;33(7):1870-4. doi: 10.1093/molbev/msw054. Epub 2016 Mar 22.
4
Therapeutic Use of Native and Recombinant Enteroviruses.天然和重组肠道病毒的治疗用途。
Viruses. 2016 Feb 23;8(3):57. doi: 10.3390/v8030057.
5
Eight years of experience with molecular identification of human enteroviruses.人类肠道病毒分子鉴定的八年经验
J Clin Microbiol. 2008 Jul;46(7):2410-3. doi: 10.1128/JCM.00313-08. Epub 2008 May 7.
6
Epidemiological, molecular, and clinical features of enterovirus respiratory infections in French children between 1999 and 2005.1999年至2005年法国儿童肠道病毒呼吸道感染的流行病学、分子学及临床特征
J Clin Microbiol. 2008 Jan;46(1):206-13. doi: 10.1128/JCM.01414-07. Epub 2007 Nov 14.
7
Complete genome sequences of all members of the species Human enterovirus A.人类肠道病毒A所有成员的全基因组序列
J Gen Virol. 2004 Jun;85(Pt 6):1597-1607. doi: 10.1099/vir.0.79789-0.
8
Comparison of the complete nucleotide sequences of echovirus 7 strain UMMC and the prototype (Wallace) strain demonstrates significant genetic drift over time.埃可病毒7型UMMC株与原型（华莱士）株的完整核苷酸序列比较显示，随着时间推移存在显著的基因漂移。
J Gen Virol. 2001 Nov;82(Pt 11):2629-2639. doi: 10.1099/0022-1317-82-11-2629.
Zotero 插件